Renewed calls for Tasmanian medical cannabis trials to include larger scope of patients
Parents and carers have appealed for Australian medicinal cannabis trials to encompass patients a broader range of patients.
The $9 million New South Wales trial is open to children with severe, drug-resistant epilepsy, and adults who are terminally ill or have chemotherapy-induced illnesses.
The Tasmanian Government said it was cooperating with the program, and that Tasmanians may take part when the trial was underway.
But carer Nicole Cowes, whose daughter Alice has an epileptic condition known as CDKL5, said despite her daughter’s severe illness, it was unlikely she would be included in the trial.
– Read the entire article at ABC News.